Vilket är priset för Polydex Pharmaceuticals Limited (POLXF)

Priset för Polydex Pharmaceuticals Limited (POLXF) är $1.99

Vilket är marknadsvärdet för Polydex Pharmaceuticals Limited (POLXF)

Marknadsvärdet för Polydex Pharmaceuticals Limited (POLXF) är $6.82M

Polydex Pharmaceuticals Limited (POLXF) Intäkter

Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was incorporated in 1979 and initially operated as Polydex Chemicals Limited before adopting its current name in March 1984. PPL specializes in the research, development, manufacturing, and global marketing of biotechnology-derived products for the human pharmaceutical sector. Beyond its human health focus, PPL also produces vital pharmaceutical intermediates for the veterinary industry. Its core product line centers on dextran and its various derivatives. Notable examples include iron dextran, a compound administered to newborn pigs to combat anemia, and dextran sulphate, a specialized chemical derivative crucial for biotechnology applications and the broader pharmaceutical sector. Furthermore, the company is actively developing Ushercell, a high molecular weight cellulose sulphate. This innovative product is designed for topical vaginal use, primarily aimed at preventing the transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies. PPL's portfolio further extends to supplying ferric hydroxide and hydrogenated dextran solutions. Products reach the market through a combination of independent distributors, wholesalers, and direct sales channels to various companies.

År	Intäkter	Ändra
Inte tillräckligt med data för de angivna datumen.

År

Intäkter

Ändra

Inte tillräckligt med data för de angivna datumen.

Företag	Intäkter	Intäktsdifferens	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$12.62B	-	US
Argenx SE ARGX.US	$6.02B	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$10.11B	-	BE

Företag

Intäkter

Intäktsdifferens

Land